Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance DOI Creative Commons
Haozhe Huang,

Yiqing Mu,

Yixian Huang

et al.

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 5, 2025

Language: Английский

Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance DOI Creative Commons
Haozhe Huang,

Yiqing Mu,

Yixian Huang

et al.

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 5, 2025

Language: Английский

Citations

0